Found: 2
Select item for more details and to access through your institution.
Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e115, doi. 10.1016/j.clml.2019.09.191
- By:
- Publication type:
- Article
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E5, doi. 10.1002/ajh.26010
- By:
- Publication type:
- Article